Efficacy of NS5A inhibitors against unusual and potentially difficult-to-treat HCV subtypes commonly found in sub Saharan Africa and South East Asia - Nguyen, D; Smith, D; Vaughan-Jackson, A (J Hepatol, 2020)
et al.